Our findings suggest that the combined expression of C46 HIV-1 fusion inhibitor on cell membranes of HIV-1 target cells in combination with CRISPR/Cas9-mediated CCR5 knockout strategy provide an alternative approach of genetic engineering for cellular resistance to a broad range of HIV-1 infections. This evidence concerns the gene CCR5 and HIV-1 infection.